Clinical Trial Detail

NCT ID NCT03042689
Title Study of Regorafenib in Patients With Advanced Myeloid Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Massachusetts General Hospital
Indications

acute myeloid leukemia

myelodysplastic syndrome

myelofibrosis

Therapies

Regorafenib

Age Groups: adult senior

No variant requirements are available.